ClinicalTrials.Veeva

Menu

Medium and Long Term Outcome of Total Hip Arthroplasty Using Accolade TMZF Femoral Stem

Rothman Institute Orthopaedics logo

Rothman Institute Orthopaedics

Status

Unknown

Conditions

Osteoarthritis of the Hip

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT00951145
RIFJPAR 09-01

Details and patient eligibility

About

This is a retrospective/prospective study evaluating the clinical and radiographic outcome of total hip arthroplasty (THA) performed using Accolade femoral stem in a consecutive group of patients. All patients eligible for inclusion will be identified. The investigators hypothesize that the outcome of THA performed using Accolade femoral stem is equal or superior to historical survivorship of THA using other types of collarless, proximally coated, tapered stems.

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  1. All patients undergoing THA prior to 1/1/2003 using Accolade femoral stem.
  2. Patients with hip fracture undergoing THA will also be included.
  3. Patients willing and able to comply with follow-up requirements and self-evaluations.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems